Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
210.00    -2.50 (-1.18%)
Bid:
205.00
Ask:
215.00
Spread: 10.00 (4.878%)
Market Cap: £63.15m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Director/PDMR Dealing

2 May 2025 13:03

RNS Number : 2885H
Mpac Group PLC
02 May 2025
 

2 May 2025

 

Mpac Group plc

("Mpac" or the "Company")

 

Director/PDMR Dealing

 

Mpac Group plc,  the global packaging and automation solutions Group, announces that it has been informed that today Adam Holland, Chief Executive Officer, was awarded 6,548 ordinary shares of 25 pence each ("Ordinary Shares") and William Wilkins, Group Finance Director, was awarded 5,238 Ordinary Shares at a price of 408 pence per Ordinary Share. The Company's Employee Benefit Trust purchased shares from the market to satisfy these awards.

The Remuneration Committee and the Board undertook a review of the incentives provided to the Executive Directors and observed that, especially at the commencement of their tenure, there was limited alignment between the interests of the shareholders and the Executive Directors. In addition, the Remuneration Committee determined that the overall incentive outcome did not adequately reflect the transformation of the Group in 2024. For these reasons, the Remuneration Committee, with the agreement of the Board, recommended that the awards be made.

 

These shares will be required to be held for a period of two years.

 

Mr Holland's shareholding following this transaction is 24,228 Ordinary Shares, representing c.0.08% of the Company's issued share capital.

 

Mr Wilkins's shareholding following this transaction is 96,432 Ordinary Shares, representing c.0.32% of the Company's issued share capital.

 

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of a transaction by a person discharging managerial responsibilities ("PDMR").

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Adam Holland

2

Reason for the notification

a)

Position/status

Chief Executive Officer / PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Exceptional award of Ordinary Shares

c)

Price(s) and volume(s)

6,548 Ordinary Shares

408 pence

d)

Aggregated information

- Volume 

- Price

- Total

N/A

e)

Date of the transaction

2 May 2025

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

William Wilkins

2

Reason for the notification

a)

Position/status

Chief Financial Officer / PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Exceptional award of Ordinary Shares

c)

Price(s) and volume(s)

5,238 Ordinary Shares

408 pence

d)

Aggregated information

- Volume 

- Price

- Total

N/A

e)

Date of the transaction

2 May 2025

f)

Place of the transaction

Outside a trading venue

 

 

For further information please contact:

 

Mpac Group plc

Adam Holland, Chief Executive Officer

Will Wilkins, Chief Financial Officer

 

 

Tel: +44 (0)24 7642 1100

 

 

Shore Capital (Nomad and Joint Broker)

Advisory

Patrick Castle

Sophie Collins

 

Broking

Henry Willcocks

 

Tel: +44 (0)20 7408 4050

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Will King

Freddie Wooding

 

 

Tel: +44 (0)20 3100 2000

Hudson Sandler (Financial PR)

Nick Lyon

Nick Moore

Francesca Rosser

 

Tel: +44 (0) 20 7796 4133

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLLLFBEELBBBB
Date   Source Headline
5th Sep 20197:00 amRNSHalf-year results
8th Aug 20192:03 pmRNSNotice of Results
16th Jul 201911:07 amRNSSecond Price Monitoring Extn
16th Jul 201911:01 amRNSPrice Monitoring Extension
16th Jul 20197:00 amRNSTrading Update
12th Jun 20193:30 pmRNSAwards under Long Term Incentive Plan
11th Jun 20197:00 amRNSPension scheme valuation update
3rd May 20193:15 pmRNSDirector/PDMR Shareholding
3rd May 20191:23 pmRNSTR-1
3rd May 20191:19 pmRNSAwards under Deferred Share Plan
2nd May 20194:14 pmRNSResult of AGM
1st May 20197:00 amRNSAcquisition of Lambert and Trading Update
3rd Apr 20193:57 pmRNSPosting of 2018 Annual Report and Notice of AGM
5th Mar 20197:00 amRNSFinal results for the year ended 31 December 2018
30th Jan 20197:00 amRNSNotice of Results
7th Jan 20197:00 amRNSYear-end trading update
1st Nov 20187:00 amRNSDirectorate Appointment
6th Sep 20185:21 pmRNSDirector/PDMR Shareholding
6th Sep 20184:41 pmRNSSecond Price Monitoring Extn
6th Sep 20184:36 pmRNSPrice Monitoring Extension
6th Sep 20187:00 amRNSHalf-year results
20th Aug 201810:55 amRNSNotice of Results - Replacement
3rd Aug 201811:30 amRNSNotice of Results
18th Jul 20185:49 pmRNSHolding(s) in Company
18th Jul 201811:06 amRNSSecond Price Monitoring Extn
18th Jul 201811:01 amRNSPrice Monitoring Extension
18th Jul 20187:00 amRNSHalf- Year Trading Update
22nd Jun 20187:00 amRNSDirectorate Change
3rd May 20185:12 pmRNSDirectorate Change
19th Apr 20182:07 pmRNSResult of AGM and Board Changes
19th Apr 20187:00 amRNSAGM statement and Board Change
21st Mar 201810:02 amRNSPosting of 2017 Annual Report and Notice of AGM
16th Mar 201811:38 amRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSFinal Results for the year to 31 December 2017
14th Feb 20187:00 amRNSNotice of Results
26th Jan 20187:00 amRNSChange of name to Mpac Group plc
22nd Jan 201811:11 amRNSResult of General Meeting and Change of Name
3rd Jan 201812:28 pmRNSProposed name change and notice of General Meeting
2nd Jan 20184:20 pmRNSDisposal
5th Dec 20177:00 amRNSDisposal
10th Oct 20173:39 pmRNSChange of Registered Office
14th Sep 201711:16 amRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSHalf-year Report
1st Sep 201712:05 pmRNSDirectorate Change
22nd Aug 201710:31 amRNSNotice of Half Year Results
1st Aug 20172:50 pmRNSCompletion of disposal
12th Jul 20177:00 amRNSDirectorate Change
29th Jun 20179:14 amRNSHolding(s) in Company
27th Jun 20172:33 pmRNSResult of General Meeting
27th Jun 20177:00 amRNSHalf-Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.